Keywords: Ablynx, Merck Serono, Merck KGaA, ALX-0761, Autoimmune diseases

Ablynx earns milestone from Merck Serono

Article | 13 December 2011

Print This

Belgium’s Ablynx (Euronext Brussels: ABLX) says it will earn a 1 million-euro ($1.3 million) from partner Merck Serono, a division ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in